Summit Creek Advisors LLC boosted its holdings in HealthEquity, Inc. (NASDAQ:HQY - Free Report) by 11.0% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 285,913 shares of the company's stock after acquiring an additional 28,424 shares during the quarter. HealthEquity accounts for 3.6% of Summit Creek Advisors LLC's portfolio, making the stock its largest position. Summit Creek Advisors LLC owned about 0.33% of HealthEquity worth $27,433,000 as of its most recent SEC filing.
Other hedge funds have also recently added to or reduced their stakes in the company. Smartleaf Asset Management LLC lifted its stake in shares of HealthEquity by 34.3% in the 4th quarter. Smartleaf Asset Management LLC now owns 384 shares of the company's stock worth $37,000 after acquiring an additional 98 shares during the period. Louisiana State Employees Retirement System lifted its position in HealthEquity by 0.4% in the fourth quarter. Louisiana State Employees Retirement System now owns 24,200 shares of the company's stock worth $2,322,000 after purchasing an additional 100 shares during the period. Oregon Public Employees Retirement Fund boosted its stake in HealthEquity by 0.6% during the 4th quarter. Oregon Public Employees Retirement Fund now owns 17,776 shares of the company's stock valued at $1,706,000 after purchasing an additional 100 shares in the last quarter. State of Michigan Retirement System increased its position in shares of HealthEquity by 0.5% during the 4th quarter. State of Michigan Retirement System now owns 20,722 shares of the company's stock valued at $1,988,000 after purchasing an additional 100 shares during the period. Finally, Commonwealth of Pennsylvania Public School Empls Retrmt SYS raised its stake in shares of HealthEquity by 0.6% in the 4th quarter. Commonwealth of Pennsylvania Public School Empls Retrmt SYS now owns 19,286 shares of the company's stock worth $1,850,000 after buying an additional 106 shares in the last quarter. Institutional investors own 99.55% of the company's stock.
Analysts Set New Price Targets
Several brokerages recently weighed in on HQY. Barrington Research reaffirmed an "outperform" rating and set a $112.00 target price on shares of HealthEquity in a research note on Friday, March 14th. JMP Securities lifted their price objective on shares of HealthEquity from $105.00 to $107.00 and gave the stock a "market outperform" rating in a research note on Tuesday, December 10th. Raymond James raised shares of HealthEquity from an "outperform" rating to a "strong-buy" rating and cut their target price for the company from $120.00 to $115.00 in a research note on Tuesday. KeyCorp decreased their price target on shares of HealthEquity from $120.00 to $110.00 and set an "overweight" rating on the stock in a research report on Monday. Finally, Wells Fargo & Company increased their price objective on HealthEquity from $110.00 to $125.00 and gave the company an "overweight" rating in a research report on Wednesday, February 26th. One investment analyst has rated the stock with a hold rating, eleven have assigned a buy rating and one has issued a strong buy rating to the company. According to MarketBeat, HealthEquity presently has an average rating of "Buy" and an average target price of $112.23.
Get Our Latest Analysis on HealthEquity
HealthEquity Stock Up 1.1 %
NASDAQ:HQY traded up $1.02 during trading hours on Thursday, hitting $90.24. 644,289 shares of the company's stock traded hands, compared to its average volume of 705,605. HealthEquity, Inc. has a twelve month low of $65.01 and a twelve month high of $115.59. The firm has a market cap of $7.81 billion, a P/E ratio of 82.80, a P/E/G ratio of 1.60 and a beta of 0.62. The company has a debt-to-equity ratio of 0.51, a quick ratio of 3.20 and a current ratio of 3.20. The stock's fifty day moving average price is $104.17 and its two-hundred day moving average price is $95.89.
Insider Transactions at HealthEquity
In related news, Director Robert W. Selander sold 5,750 shares of HealthEquity stock in a transaction on Monday, February 10th. The stock was sold at an average price of $111.29, for a total transaction of $639,917.50. Following the completion of the sale, the director now owns 78,219 shares of the company's stock, valued at approximately $8,704,992.51. This trade represents a 6.85 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. 2.20% of the stock is owned by insiders.
HealthEquity Company Profile
(
Free Report)
HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.
Recommended Stories

Before you consider HealthEquity, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and HealthEquity wasn't on the list.
While HealthEquity currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Thinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.